BETA

6 Amendments of Javier MORENO SÁNCHEZ related to 2020/2071(INI)

Amendment 2 #
Draft opinion
Paragraph 1
1. Notes that the COVID-19 pandemic has revealed in the starkest possible terms the vital role played by functioning global supply chains for medical products, and in particular for medicines; emphasises that the implementation of an open, rules- based trading system is fundamental to ensuring the global availability of medicines and that our vulnerability is not repeated in future emergencies;
2020/05/18
Committee: INTA
Amendment 11 #
Draft opinion
Paragraph 2
2. Recognises that the EU depends on a narrow set of countries for a large proportion of its imports of active pharmaceutical ingredients and chemical raw materials; stresses that this over- reliance can pose a risk when limitations in production capacity, excess demand or protectionist measures threaten the proper functioning of global supply chains and potentially undermine the availability of medicines in the EU; calls on the Commission to present a long-term strategy focused on ensuring the EU’s open strategic autonomy in healthand Member States to take the necessary legislative measures, policies and incentives to encourage the production of essential APIs and medicines in Europe to guarantee supply at all times and reduce supply dependence from third countries;
2020/05/18
Committee: INTA
Amendment 44 #
Draft opinion
Paragraph 4
4. Emphasises that a broad network of fair and well implemented FTAs together with a functioning multilateral trading system constitute the best way of guaranteeing that multiple sources of manufacturing for essential medicines are available and regulatory standards converge globally;
2020/05/18
Committee: INTA
Amendment 66 #
Draft opinion
Paragraph 6 a (new)
6 a. Highlights the importance that the European Commission takes all necessary measures to combat speculation, fraud and price abuses in the trade of essential medical substances;
2020/05/18
Committee: INTA
Amendment 68 #
Draft opinion
Paragraph 6 b (new)
6 b. Calls on the Commission to exercise leadership at global level to ensure that developing countries have guaranteed access to and supply of essential medicines, especially in emergencies;
2020/05/18
Committee: INTA
Amendment 69 #
Draft opinion
Paragraph 6 c (new)
6 c. Stresses the importance of ensuring universal access to vaccines and medical treatment, especially in cases of emergency and for new diseases for which no treatment exists, as in the case of Covid-19; urges a close collaboration between the WHO and the WTO to ensure the supply of the vaccine once it is found; at the same time, calls on the Commission to strengthen its mechanisms for the joint procurement of medicines in order to guarantee universal access to treatment for all citizens regardless of their place of residence.
2020/05/18
Committee: INTA